Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.21 - $5.63 $3,856 - $103,400
18,366 Added 139.78%
31,505 $8,000
Q3 2022

Nov 14, 2022

BUY
$0.46 - $6.75 $1,370 - $20,108
2,979 Added 29.32%
13,139 $5,000
Q2 2022

Aug 16, 2022

BUY
$0.27 - $0.61 $2,743 - $6,197
10,160 New
10,160 $5,000
Q4 2021

Feb 15, 2022

SELL
$0.58 - $1.09 $15,796 - $29,686
-27,235 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$0.93 - $1.18 $25,328 - $32,137
27,235 New
27,235 $31,000
Q3 2020

Nov 17, 2020

SELL
$0.8 - $2.33 $47,548 - $138,483
-59,435 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$0.75 - $1.29 $44,576 - $76,671
59,435 New
59,435 $49,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $1.12B
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.